Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-27

Clinical Trial Update: Urtica Comp. Gel for Prevention and Therapy of Radiation Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing Urtica Comp. Gel for prevention and therapy of radiation dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Urtica Comp. Gel

Snippet

Sponsor: University of Bern | Conditions: Radiation Dermatitis | Phase 2 | Status: COMPLETED